INVESTMENT THEME
Gene Editing (CRISPR) stocks
CRISPR Therapeutics' CFO change puts cash runway and pipeline execution under scrutiny, keeping near-term share volatility elevated.
Constituents today, average +4.02% · Updated 2026-10-28 22:24 UTC+8
Constituents
| Stock | Price (USD) | Today |
|---|---|---|
| CRSP CRISPR Tx | 52.15 | +1.32% |
| NTLA Intellia | 12.83 | +4.48% |
| BEAM Beam | 26.46 | +6.27% |
US-listed shares and ADRs. Tickers link to key levels where we cover the stock.
Latest related news
Learn Why The Bull Case For CRISPR Therapeutics Stock Could Change Following CFO Change — Yahoo
Other themes
AI & Robotics +0.48%Solar & Storage -6.43%BoJ Normalization -0.41%Caffeinated Drinks -0.11%Luxury Groups -0.25%P&C Insurance +0.16%Weight-Loss Drugs (GLP-1) +0.04%Rare Earths & Critical Minerals -2.23%Quantum Computing -2.08%Large Language Models -0.39%Autonomous Driving -0.18%AI Medical Imaging +4.70%Cardiovascular Innovators +0.29%Streaming Platforms -5.42%Pet Economy +0.20%Small Modular Reactors (SMR) -1.65%Grid & Storage Upgrades -0.27%
Follow this theme in the app
Theme prices, news and constituent charts are in the app, along with one-sentence screening across 8 markets.
Theme constituents are compiled by our research team. For information only; not investment advice or a recommendation.